Ketohydroxy-Estratriene en es it fr

Ketohydroxy-Estratriene Brand names, Ketohydroxy-Estratriene Analogs

Ketohydroxy-Estratriene Brand Names Mixture

  • Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
  • Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)

Ketohydroxy-Estratriene Chemical_Formula


Ketohydroxy-Estratriene RX_link

No information avaliable

Ketohydroxy-Estratriene fda sheet

Ketohydroxy-Estratriene msds (material safety sheet)

Ketohydroxy-Estratriene MSDS

Ketohydroxy-Estratriene Synthesis Reference

G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)

Ketohydroxy-Estratriene Molecular Weight

270.366 g/mol

Ketohydroxy-Estratriene Melting Point

254.5-256 oC

Ketohydroxy-Estratriene H2O Solubility

3 g/100mL

Ketohydroxy-Estratriene State


Ketohydroxy-Estratriene LogP


Ketohydroxy-Estratriene Dosage Forms

Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension

Ketohydroxy-Estratriene Indication

For management of Menopausal and postmenopausal disorders

Ketohydroxy-Estratriene Pharmacology

Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.

Ketohydroxy-Estratriene Absorption


Ketohydroxy-Estratriene side effects and Toxicity

Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.

Ketohydroxy-Estratriene Patient Information

Ketohydroxy-Estratriene Organisms Affected

Humans and other mammals